kronos scientifica

We are medical affairs professionals here to help you optimize and accelerate product adoption through the execution of medical affairs strategies.

[kronos scientifica @kronossci]

🔮 Our prediction: This year, 40%+ of healthcare M&A deals will involve digital health assets, with cross-border partnerships surging. The challenge? Integrating tech into pharma pipelines with long ROI cycles. #BiotechMA #DigitalHealth #kronosscientifica #KPMG

[kronos scientifica @kronossci]

The FDA's acceptance of deidentified real-world evidence for medical devices is a game-changer. Expect 30% of new device applications to include RWE in 2026, reshaping regulatory strategy. https://t.co/2jE4mHlWXY

#RealWorldEvidence #FDA #kronosscientifica

[kronos scientifica @kronossci]

AI-designed antibodies are leading the race for the first AI-driven drug approval. But the real hurdle? Regulatory scrutiny of AI-driven trial data. Expect frameworks to evolve by 2027. Link here: https://t.co/wauuNMiGpk #AIinDrugDiscovery #Biotech #kronosscientifica

[kronos scientifica @kronossci]

A new blood cancer therapy reverses "incurable" leukemia in some patients. Expect a 50% surge in trials for advanced hematologic treatments within 3 years. The challenge? Scaling access to these complex therapies. Link here: https://t.co/kSa63f6RHh #Oncology #kronosscientifica

[kronos scientifica @kronossci]

This year has been about helping emerging biotechs and medtech innovators tell their scientific story with more clarity, more confidence, and more impact.

None of that would happen without partners and colleagues like you.

Wishing you a warm and joyful Thanksgiving!

[kronos scientifica @kronossci]

The future of biotech isn’t built in silos.

At kronos scientifica (@KronosSci), we connect science, strategy, and storytelling — helping emerging biotechs turn data into credible evidence, and evidence into impact.

#MedTech #biotech #pharma

[kronos scientifica @kronossci]

Most biotech stories die in translation — between discovery and strategy.

@kronossci bridges that gap.

Follow us if you’re building what’s next in biotech, digital health, or medical strategy.

Smart ideas deserve smarter execution.

#Biotech #LifeSciences #scientificasessions

[kronos scientifica @kronossci]

🎙️ kronos scientifica has launched our new podcast: scientifica sessions.

We sit down with Tom Neyarapally, CEO of Archetype Therapeutics.

✨ Episode 1 is live.Listen on Spotify: https://t.co/57wMy8Eu5h

#scientificasessions #Biotech #LifeSciences #MedicalAffairs

[kronos scientifica @kronossci]

Figuring out how to integrate Medical and Commercial teams? Read here for how medical affairs contributes to sales success. #medicalaffairs #medicalstrategy

The Medical-Commercial Partnership: Empowering Sales to Enable Successful Product Adoption - https://t.co/t6XvKPxzHX

[kronos scientifica @kronossci]

You Got Approval – Now What? The Evidence Strategy You Can't Ignore. -
Click here to see why evidence generation matters! https://t.co/JdZGFMk0a0. #medicalstrategy #medicalaffairs #pharma #diagnostics #techbio #evidencegeneration

[kronos scientifica @kronossci]

You Got Approval – Now What? The Evidence Strategy You Can't Ignore. - https://t.co/VeWrXKfst4

[kronos scientifica @kronossci]

Beyond Data: Crafting Medical Narratives That Drive Clinical Adoption - https://t.co/63bqrDUsxV

[kronos scientifica @kronossci]

Beyond Data: Crafting Medical Narratives That Drive Clinical Adoption - https://t.co/zbelK7Buuv #medicalaffairs #medicalstrategy #medcomms

[kronos scientifica @kronossci]

Check this out! Are you launching a new pharma/biotech/diagnostic product?
Do you have a medical strategy? Here's why it's important - Medical Strategy for Market Success - https://t.co/jiK86meWgu

[kronos scientifica @kronossci]

Strategic Medical Insights for Life Sciences CEOs - https://t.co/pKGu0Z1KOf

[kronos scientifica @kronossci]

🚀 Introducing Kronos Scientifica—your medical affairs strategic partner.

🔬 Accelerating diagnostic, therapeutic, and medtech product adoption.

✨ Bespoke solutions. Clinical expertise. Optimized commercialization.

https://t.co/bfgrADsFfq

#MedAffairs #Biotech #LaunchSmarter